Afalaza
Materia Medica
936 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Prostate hyperplasia is a benign treatment agent.
Indications
Benign prostatic hyperplasia of stage I and II.
In the complex treatment of acute and chronic prostatitis - as an anti-inflammatory and analgesic.
Dysuric disorders (frequent urge to urinate, difficulty urinating, pain and discomfort in the perineal region).
Erectile dysfunction (erectile dysfunction) of various origin.
Vegetative menopausal disorders in men (weakness, fatigue, decreased physical activity, decreased libido, etc.).
Combined therapy used before and after surgery on the prostate gland.
Composition
Active substances:
Antibodies to endothelial NO-synthase affinity purified - 0.006 g *
Antibodies to prostate-specific antigen, affinity-purified - 0.006 g. *
Excipients:
lactose monohydrate, microcrystalline cellulose, magnesium stearate.
* applied to lactose in the form of a mixture of three active aqueous-alcoholic dilutions of the substance, diluted 10012, 10030, 100200 times, respectively
No customer reviews for the moment.
Dosage and Administration
For oral use. At one time - 2 pills (keep in the mouth until completely dissolved - not during the meal). The drug is taken twice a day, in the evening and in the morning. The recommended duration of the drug is 16 weeks.
With severe pain syndrome and dysuric disorders in the first 2-3 weeks of therapy, the drug is indicated to be taken up to 4 times a day.
If necessary, on the recommendation of a doctor, it is possible to repeat the course of treatment in 1-4 months.
Adverse reactions
When using the drug for the indicated indications and in the indicated dosages, no side effects were revealed.
Contraindications
Increased individual sensitivity to the components of the drug.
Drug interactions
Cases of incompatibility with other drugs so far not registered.
Special instructions
The preparation contains lactose, and therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose malabsorption or galactose syndrome, or in congenital lactase deficiency. Afalaza does not affect the ability to drive vehicles and other potentially dangerous machinery.
Overdosage
In case of accidental overdose, dyspeptic symptoms are possible due to the fillers in the preparation.
- Brand name: Afalaza
- Active ingredient: Homeopathic composition
- Dosage form: pills of a flat-cylindrical form, with risky and a facet, from white to almost white color. The inscription MATERIA MEDICA is inscribed on the flat side, and the inscription AFALAZA is inscribed on the other flat side.
- Manufacturer: Materia Medica
- Country of Origin: Russia
8 other products in the same category:
arrow_upward